Risk of severe esophageal stricture among childhood cancer survivors – A population-based case-cohort study within the Adult Life after Childhood Cancer in Scandinavia (ALiCCS)

Autor: Helena K. Hansen, Peter H. Asdahl, Jane Christensen, Camilla Pedersen, Anja Krøyer, Celina S. Pontoppidan, Anna S. Holmqvist, Lars Hjorth, Thomas Wiebe, Thorgerdur Gudmundsdottir, Sofie de fine Licht, Yasmin Lassen-Ramshad, Klaus Seiersen, Morten Jørgensen, Michael RT Laursen, Hilde Øfstaas, Päivi M. Lähteenmäki, Susan A. Smith, Rebecca Howell, Catherine Rechnitzer, Henrik Hasle, Jeanette F. Winther, Line Kenborg

Publikováno v: EJC Paediatric Oncology, Vol 4, Iss , Pp 100195- (2024)

Purpose: Due to limited data on treatment-related risk factors associated with esophageal stricture in childhood cancer survivors, this study aimed to assess such factors in long-term survivors. Methods: A case-cohort study was conducted involving 36

Externí odkaz: https://doaj.org/article/5ca42bec0cf6407f8215c1dbc49807c6

Effects of early maternal cancer and fertility treatment on the risk of adverse birth outcomes

Autor: Cathrine Everhøj, Filippa Nyboe Norsker, Catherine Rechnitzer, Sofie de Fine Licht, Thomas T Nielsen, Susanne K. Kjær, Allan Jensen, Marie Hargreave, Jane Christensen, Federica Belmonte, Stine Kjaer Urhoj, Katrine Strandberg-Larsen, Jeanette F Winther, Line Kenborg

Publikováno v: EClinicalMedicine, Vol 46, Iss , Pp 101369- (2022)

Summary: Background: Early maternal cancer and fertility treatment each increase the risk for adverse birth outcomes, but the joint effect of these outcomes has not yet been reported. Thus, the aim was to assess the individual and joint effect of mat

Externí odkaz: https://doaj.org/article/a2f0221eafa849108abf82ac7cdd4ae2

Short-acting β

Autor: Erik, Melén, Bright I, Nwaru, Fredrik, Wiklund, Sofie, de Fine Licht, Gunilla, Telg, Ekaterina, Maslova, Ralf J P, van der Valk, Trung N, Tran, Magnus, Ekström, Christer, Janson

Publikováno v: Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and ImmunologyREFERENCES. 33(11)

In adults and adolescents with asthma, use of ≥3 short-acting βThis population-based cohort study utilized linked data from the Swedish national healthcare registries involving patients with asthma (18 years) treated in secondary care between 2006

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::f0bcc359aa8831ec4b67e4b3a94e4f7f
https://pubmed.ncbi.nlm.nih.gov/36433853

Disease Trajectories and Impact of One Moderate Exacerbation in Gold B COPD Patients

Autor: Anders Løkke, Ole Hilberg, Peter Lange, Rikke Ibsen, Georgios Stratelis, Sofie de Fine Licht, Jesper Lykkegaard

Publikováno v: Løkke, A, Hilberg, O, Lange, P, Ibsen, R, Stratelis, G, de Fine Licht, S & Lykkegaard, J 2022, ' Disease Trajectories and Impact of One Moderate Exacerbation in Gold B COPD Patients ', International Journal of Chronic Obstructive Pulmonary Disease, vol. 17, pp. 569-578 . https://doi.org/10.2147/COPD.S344669
Lokke, A, Hilberg, O, Lange, P, Ibsen, R, Stratelis, G, Licht, S D F & Lykkegaard, J 2022, ' Disease Trajectories and Impact of One Moderate Exacerbation in Gold B COPD Patients ', International journal of chronic obstructive pulmonary disease, vol. 17, pp. 569-578 . https://doi.org/10.2147/COPD.S344669

Anders Løkke,1,2 Ole Hilberg,1,2 Peter Lange,3,4 Rikke Ibsen,5 Georgios Stratelis,6,7 Sofie de Fine Licht,6 Jesper Lykkegaard8 1Department of Medicine, Little Belt Hospital, Vejle, Denmark; 2Department of Regional Health Research, University of So

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::959121dd6a3f4560786350e8b306d770
https://findresearcher.sdu.dk:8443/ws/files/201080637/Open_Access_Version.pdf

Short-acting β2 -agonist use and asthma exacerbations in Swedish children : A SABINA Junior study

Autor: Erik Melén, Bright I. Nwaru, Fredrik Wiklund, Sofie de Fine Licht, Gunilla Telg, Ekaterina Maslova, Ralf J. P. van der Valk, Trung N. Tran, Magnus Ekström, Christer Janson

BACKGROUND: In adults and adolescents with asthma, use of ≥3 short-acting β2 -agonist (SABA) canisters/year is associated with increased exacerbation risk. Whether this association is present in younger children remains unknown. In this SABA use I

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::15ae7802ad34973ac2cd75bc94373739
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-492866